Blood Banking MCQs:
These 300+ multiple-choice questions (MCQs) are designed to test your knowledge and understanding of various aspects of blood banking, a critical component of transfusion medicine. Blood banking involves the collection, processing, testing, storage, and distribution of blood and blood components to ensure their safe and effective use in medical treatments. The questions cover a wide range of topics, including blood typing, compatibility testing, transfusion reactions, blood component therapy, and the management of adverse events. By answering these questions, you will gain a deeper insight into the complexities and importance of blood banking in modern healthcare.
A. a false-positive result due to antigen excess
B. a false-positive result due to the prozone phenomenon
C. a false-negative result due to the prozone phenomenon ✅
D. a false-negative result due to an antigen excess
A. anti-M
B. anti-E
C. anti-c
D. anti-Fya ✅
A. phenotype his cells to determine which additional alloantibodies may be produced
B. recommend the use of directed donors, which are more likely to be compatible
C. use proteolytic enzymes to destroy the “in vitro” activity of some of the antibodies
D. freeze the patient’s serum to use for antigen typing of compatible units ✅
A. Rh
B. I
C. P
D. Duffy ✅
A. anti-Lea
B. anti-s
C. anti-k
D. anti-E ✅
A. anti-Ch
B. anti-k
C. anti-e
D. anti-Jsb ✅
Antigens | 1 | 2 | 3 | 4 | 5 | Test results |
---|---|---|---|---|---|---|
Panel cells I | + | 0 | 0 | + | + | + |
Panel cells II | 0 | 0 | + | 0 | + | 0 |
Panel cells III | 0 | + | + | + | 0 | 0 |
Panel cells IV | 0 | + | + | 0 | + | + |
Panel cells V | + | + | + | 0 | 0 | + |
auto | 0 |
A. 1
B. 2
C. 3
D. 4 ✅
A. anti-F
B. anti-Lea
C. anti-C
D. anti-Fya ✅
A. no clinically significant red cell destruction
B. clinically significant immune red cell destruction
C. decreased 51Cr red cell survivals
D. febrile transfusion reactions ✅
A. serum testing against red cells from random donors
B. serum testing against red cells known to lack high incidence antigens ✅
C. serum testing against enzyme-treated autologous red cells
D. testing of an eluate prepared from the patient’s red cells
Forward group: | Reverse group: | ||||
---|---|---|---|---|---|
anti-A | anti-B | anti-A1lectin | A1cells | A2cells | B cells |
4+ | 0 | 4+ | 0 | 2+ | 4+ |
A. anti-A1 ✅
B. rouleaux
C. anti-H
D. unexpected IgG antibody present
A. detected at IAT phase and may cause hemolytic disease of the fetus and newborn(HDFN) and transfusion reactions ✅
B. not deteted with enzyme treated cells; may cause delayed transfusion reactions
C. requires the IAT technique for detection; usually not responsible for causing HDFN
D. may show dosage effect; may cause severe hemolytic transfusion reactions
A. direct antiglobulin ✅
B. complement fixation
C. indirect antiglobulin
D. immunofluorescence
A. anti-I agglutinating the cells
B. C3d bound to the red cells ✅
C. T-activation
D. C3c remaining on the red cells after cleavage of C3b
Test result | Polyspecific | IgG | C3 | Control |
---|---|---|---|---|
result A | +mf | +mf | 0 | 0 |
result B | 1+ | 0 | 1+ | 0 |
result C | 2+ | 2+ | 0 | 0 |
result D | 4+ | 4+ | 4+ | 0 |
A. result A
B. result B
C. result C
D. result D ✅
A. IgG and IgA
B. IgG and C3d ✅
C. IgM and IgA
D. IgM and C3d
A. mediate hemolysis of indicator red blood cells by providing complement
B. precipitate anti-erythrocyte antibodies
C. measure antibodies in a test serum by fixing complement
D. detect preexisting antibodies on erythrocytes ✅
A. can be used as a positive control for anti-C3 reagents
B. can be used only for the indirect antiglobulin test
C. are coated only with IgG antibody
D. must be used to confirm all positive antiglobulin reactions ✅
A. IgM ✅
B. IgG
C. C3d
D. C4a